Population
In vitro models studying human rhinovirus type 2 2A proteinase (HRV2 2A)
Comparison
Zinc chelator or specific mutation preventing… vs Wild-type HRV2 2A(pro) or absence of zinc chelator
Design
Preclinical
Authors
Loading...
Zinc chelation may inhibit HRV 2A(pro); hypothesis-generating for antivirals and leaves open in vivo efficacy before any clinical consideration.
Self-processing of HRV2 2A(pro) is required for eIF4GI cleavage, and zinc is essential for its enzymatic activity, suggesting zinc chelation as a potential antiviral strategy.
Glaser et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: